McKenna, W. J., Maron, B. J. & Thiene, G. Classification, epidemiology, and global burden of cardiomyopathies. Circ. Res. 121, 722–730 (2017).

Article  PubMed  CAS  Google Scholar 

Hershberger, R. E., Hedges, D. J. & Morales, A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat. Rev. Cardiol. 10, 531–547 (2013).

Article  PubMed  CAS  Google Scholar 

Tayal, U. et al. Precision phenotyping of dilated cardiomyopathy using multidimensional data. J. Am. Coll. Cardiol. 79, 2219–2232 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Helms, A. S., Thompson, A. D. & Day, S. M. Translation of new and emerging therapies for genetic cardiomyopathies. JACC Basic. Transl. Sci. 7, 70–83 (2022).

Article  PubMed  Google Scholar 

Arbelo, E. et al. 2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur. Heart J. 44, 3503–3626 (2023).

Article  PubMed  CAS  Google Scholar 

Rosenbaum, A. N., Agre, K. E. & Pereira, N. L. Genetics of dilated cardiomyopathy: practical implications for heart failure management. Nat. Rev. Cardiol. 17, 286–297 (2020).

Article  PubMed  Google Scholar 

McNally, E. M. & Mestroni, L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ. Res. 121, 731–748 (2017).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Herman, D. S. et al. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366, 619–628 (2012).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dellefave-Castillo, L. M. et al. Assessment of the diagnostic yield of combined cardiomyopathy and arrhythmia genetic testing. JAMA Cardiol. 7, 966–974 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Gigli, M. et al. Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 74, 1480–1490 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Eldemire, R., Mestroni, L. & Taylor, M. R. G. Genetics of dilated cardiomyopathy. Annu. Rev. Med. 75, 417–426 (2024).

Article  PubMed  CAS  Google Scholar 

Escobar-Lopez, L. et al. Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy. J. Am. Coll. Cardiol. 78, 1682–1699 (2021).

Article  PubMed  CAS  Google Scholar 

Verdonschot, J. A. J. et al. Implications of genetic testing in dilated cardiomyopathy. Circ. Genom. Precis. Med. 13, 476–487 (2020).

Article  PubMed  CAS  Google Scholar 

Asatryan, B. et al. Predicted deleterious variants in cardiomyopathy genes prognosticate mortality and composite outcomes in the UK biobank. JACC Heart Fail. 12, 918–932 (2024).

Article  PubMed  Google Scholar 

Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Amendola, L. M. et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research Consortium. Am. J. Hum. Genet. 98, 1067–1076 (2016).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bland, A. et al. Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience. Genet. Med. 20, 369–373 (2018).

Article  PubMed  Google Scholar 

Jordan, E. et al. Evidence-based assessment of genes in dilated cardiomyopathy. Circulation 144, 7–19 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ahmad, F. et al. Establishment of specialized clinical cardiovascular genetics programs: recognizing the need and meeting standards: a scientific statement from the American Heart Association. Circ. Genom. Precis. Med. 12, e000054 (2019).

Article  PubMed  Google Scholar 

Owens, A. T. & Day, S. M. Reappraising genes for dilated cardiomyopathy: stepping back to move forward. Circulation 144, 20–22 (2021).

Article  PubMed  Google Scholar 

Mazzarotto, F. et al. Reevaluating the genetic contribution of monogenic dilated cardiomyopathy. Circulation 141, 387–398 (2020).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Escobar-Lopez, L. et al. Clinical risk score to predict pathogenic genotypes in patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 80, 1115–1126 (2022).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tadros, R. et al. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect. Nat. Genet. 53, 128–134 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Garnier, S. et al. Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. Eur. Heart J. 42, 2000–2011 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kumuthini, J. et al. The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review. Hum. Genet. 141, 1697–1704 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Dominguez, F. et al. Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations. J. Am. Coll. Cardiol. 72, 2471–2481 (2018).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Akhtar, M. M. et al. Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene. Circ. Heart Fail. 13, e006832 (2020).

Article  PubMed  CAS  Google Scholar 

Wahbi, K. et al. Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies. Circulation 140, 293–302 (2019).

Article  PubMed  CAS  Google Scholar 

Towbin, J. A. et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 16, e301–e372 (2019).

Article  PubMed  Google Scholar 

Ortiz-Genga, M. F. et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J. Am. Coll. Cardiol. 68, 2440–2451 (2016).

Article  PubMed  CAS  Google Scholar 

Owen, R. et al. Sex differences in the clinical presentation and natural history of dilated cardiomyopathy. JACC Heart Fail. 12, 352–363 (2024).

Article  PubMed  PubMed Central